ArticleNucleic acids research2025
Transcriptional mechanism by which IS5 activates the fucAO operon in Escherichia coli.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Independent, ongoing clade-specific expansions of ISMicrobial genomics · 2026Article
- Investigating the Trans Effects of IS<italic>1</italic> Transposases on Intragenomic DNA Movements in <italic>Escherichia coli</italic>.Microbial physiology · 2026Article
- Examining the Roles of Genomic Context and Endogenous Regulatory Elements on ISInternational journal of molecular sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The silent E. coli fucAO operon can be activated by IS5 insertion upstream of its regulatory region, allowing cellular growth on L-1,2-propanediol. Little information is available concerning the transcriptional mechanism behind IS5-mediated fucAO activation. In this study, we demonstrate the formation of a unique "fusion" promoter (Pfsn) following IS5 insertion, which drives expression of the downstream fucAO operon. Our findings indicate that this functional σ70 fusion promoter is generated using a DNA sequence carrying a Crp-binding site directly upstream of the IS5 element, followed by the otherwise inactive IS5 transposase promoter. Under non-inducing conditions, this fusion promoter contributes to full operon expression while the native operon promoter PfucAO remains silent. As a typical Class I promoter, Pfsn is independent of the fuc regulon activator FucR, but its activity is exclusively reliant on the binding of Crp-cAMP to the upstream Crp-binding site. Under inducing conditions, the presence of functional FucR can further elevate fucAO operon expression by activating the native operon promoter, PfucAO. In the latter case, Pfsn and PfucAO function independently, and contribute to operon expression to nearly the same extent. Thus, we have discovered a novel IS-dependent fusion expression system that is modulated by a transcriptional factor in bacteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.